Results 281 to 290 of about 96,176 (305)

Intranasal administration of gold nanoparticles designed to target the central nervous system: Fabrication and comparison between nanospheres and nanoprisms

International Journal of Pharmaceutics, 2020
Andreas Tapia-Arellano, Freddy Celis, Marcelo J Kogan   +2 more
exaly  

Intranasal administration of oxytocin: Behavioral and clinical effects, a review

Neuroscience and Biobehavioral Reviews, 2013
Berend Olivier
exaly  

A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2

Cell, 2020
Natasha M Kafai, Julie M Fox, Ian B Harvey   +2 more
exaly  

INTRANASAL ADMINISTRATION OF LH‐RELEASING HORMONE

Acta Obstetricia et Gynecologica Scandinavica, 1975
O. Meirik, T. Bergh, S. J. Nillius, L. Wide   +3 more
openaire   +1 more source

Lactoferrin-modified PEG-co-PCL nanoparticles for enhanced brain delivery of NAP peptide following intranasal administration

Biomaterials, 2013
Quanyin Hu, Zhiqing Pang
exaly  

A sniff of trust: Meta-analysis of the effects of intranasal oxytocin administration on face recognition, trust to in-group, and trust to out-group

Psychoneuroendocrinology, 2012
Marinus van IJzendoorn
exaly  

DMP-755: intranasal administration feasible?

Inpharma Weekly, 1998
openaire   +1 more source

Homologous and heterologous protection after single intranasal administration of live attenuated recombinant Bordetella pertussis

Nature Biotechnology, 1998
Nathalie Mielcarek, Franck Remoue, Rudy Antoine   +2 more
exaly  

Brain delivery of vasoactive intestinal peptide enhanced with the nanoparticles conjugated with wheat germ agglutinin following intranasal administration

Journal of Controlled Release, 2007
Qizhi Zhang, Jianhua Zhu
exaly  

Chitosan coated nanostructured lipid carriers for brain delivery of proteins by intranasal administration

Colloids and Surfaces B: Biointerfaces, 2015
José Luis Pedraz, Eva Carro, Manuela Igartua   +2 more
exaly